ImmunityBio, Inc.
IBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $143 | $265 | $105 | $181 |
| Short-Term Investments | $6 | $1 | $3 | $136 |
| Receivables | $3 | $3 | $2 | $1 |
| Inventory | $8 | $0 | $0 | $0 |
| Other Curr. Assets | $24 | $24 | $32 | $16 |
| Total Curr. Assets | $185 | $294 | $141 | $334 |
| Property Plant & Equip (Net) | $170 | $183 | $189 | $119 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $16 | $17 | $20 | $1 |
| Long-Term Investments | $0 | $1 | $1 | $8 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $12 | $10 | $11 | $6 |
| Total NC Assets | $198 | $210 | $222 | $135 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $383 | $504 | $362 | $469 |
| Liabilities | – | – | – | – |
| Payables | $7 | $9 | $21 | $11 |
| Short-Term Debt | $7 | $5 | $435 | $302 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $41 | $44 | $45 | $55 |
| Total Curr. Liab. | $55 | $58 | $501 | $369 |
| LT Debt | $497 | $721 | $289 | $343 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $319 | $311 | $22 | $0 |
| Total NC Liab. | $816 | $1,032 | $311 | $344 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $42 | $45 | $51 | $40 |
| Total Liabilities | $871 | $1,090 | $812 | $713 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$3,375 | -$2,962 | -$2,378 | -$1,962 |
| AOCI | $1 | $0 | $0 | $0 |
| Other Equity | $2,885 | $2,375 | $1,931 | $1,720 |
| Total Equity | -$489 | -$587 | -$447 | -$242 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1 | $1 | -$2 | -$2 |
| Total Liab. & Tot. Equity | $383 | $504 | $362 | $469 |
| Net Debt | $361 | $461 | $619 | $465 |